Additional $12M financing led by Elevage Medical Technologies and Jonathan Milner alongside existing investors British Business Bank, and GK Goh -- The funding will accelerate development of eProtein ...

Following the installation of eProtein Discovery at leading academic institutes across the UK and Europe 1, the expansion ...

The purification of proteins and antibodies is a critical process in biotechnology and pharmaceutical industries. Traditional methods often involve single-use materials, leading to high costs and ...

TAIPEI, Taiwan & WATERTOWN, Mass.--(BUSINESS WIRE)--Syncell, a leader in next-generation subcellular protein purification and spatial proteomics analysis, today announced the close of a $15 million ...

Cambridge biotech Nuclera has boosted its Series C round to $87 million after securing a further $12m from a range of backers ...

Proteins play a key role in the life sciences -- from basic research and biotechnological applications to the development and manufacturing of pharmaceuticals. Scientists have developed a method that ...

Membrane proteins are the gateway to cells and are involved in many critical functions. Each membrane protein is unique, and their complexity makes it difficult to fit into a standardized expression ...

Cambridge biotech Nuclera is on the march globally with its much vaunted benchtop eProtein Discovery system following two ...

Nuclera has expanded its Series C funding round to USD $87 million following a new USD $12 million extension led by Elevage ...

The funding will support further development of eProtein Discovery to enable full-format antibody expression, purification, ...